19 results
Keyword Enfuvirtid Remove keyword
Categories
Human Remove Human filter
-
List item
Human medicine European public assessment report (EPAR): Fuzeon
enfuvirtide, HIV Infections
Date of authorisation: 27/05/2003, Revision: 20, AuthorisedFuzeon; INN-enfuvirtidum European Medicines … contains the active substance enfuvirtide (90 mg/ml). What is Fuzeon … active substance in Fuzeon, enfuvirtide, is a fusion inhibitor. Fuzeon … -
List item
Human medicine European public assessment report (EPAR): Prezista (updated)
darunavir, HIV Infections
Date of authorisation: 11/02/2007, Revision: 46, Authorised -
List item
Human medicine European public assessment report (EPAR): Atripla (updated)
efavirenz, emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 13/12/2007, Revision: 32, Authorised -
List item
Human medicine European public assessment report (EPAR): Stribild (updated)
elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate, HIV Infections
Date of authorisation: 24/05/2013, Revision: 21, Authorised -
List item
Human medicine European public assessment report (EPAR): Zerit
stavudine, HIV Infections
Date of authorisation: 08/05/1996, Revision: 31, Authorised -
List item
Human medicine European public assessment report (EPAR): Isentress
Raltegravir, HIV Infections
Date of authorisation: 19/12/2007, Revision: 35, Authorised -
List item
Human medicine European public assessment report (EPAR): Tivicay
dolutegravir, HIV Infections
Date of authorisation: 16/01/2014,
, Revision: 15, Authorised
-
List item
Human medicine European public assessment report (EPAR): Darunavir Krka d.d.
darunavir, HIV Infections
Date of authorisation: 18/01/2018,
, Revision: 2, Authorised
-
List item
Human medicine European public assessment report (EPAR): Viramune
nevirapine, HIV Infections
Date of authorisation: 04/02/1998, Revision: 37, Authorised -
List item
Human medicine European public assessment report (EPAR): Rezolsta
darunavir, cobicistat, HIV Infections
Date of authorisation: 19/11/2014,
, Revision: 7, Authorised
-
List item
Human medicine European public assessment report (EPAR): Telzir
fosamprenavir calcium, HIV Infections
Date of authorisation: 12/07/2004, Revision: 39, Authorised -
List item
Human medicine European public assessment report (EPAR): Aptivus
tipranavir, HIV Infections
Date of authorisation: 25/10/2005, Revision: 36, Authorised -
List item
Human medicine European public assessment report (EPAR): Daklinza
daclatasvir dihydrochloride, Hepatitis C, Chronic
Date of authorisation: 22/08/2014,, Revision: 13, Authorised
-
List item
Human medicine European public assessment report (EPAR): Zepatier
elbasvir, grazoprevir, Hepatitis C, Chronic
Date of authorisation: 22/07/2016,, Revision: 5, Authorised
-
List item
Human medicine European public assessment report (EPAR): Celsentri
maraviroc, HIV Infections
Date of authorisation: 18/09/2007, Revision: 22, Authorised -
List item
Human medicine European public assessment report (EPAR): Intelence
Etravirine, HIV Infections
Date of authorisation: 28/08/2008, Revision: 22, Authorised -
List item
Human medicine European public assessment report (EPAR): Vitekta
elvitegravir, HIV Infections
Date of authorisation: 13/11/2013,, Revision: 4, Withdrawn
-
List item
Human medicine European public assessment report (EPAR): Dutrebis
lamivudine, raltegravir potassium, HIV Infections
Date of authorisation: 26/03/2015, Withdrawn -
List item
Human medicine European public assessment report (EPAR): Nevirapine Teva
nevirapine, HIV Infections
Date of authorisation: 30/11/2009,, Revision: 8, Authorised